Ercan S - Search Results

1

The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?

Bilici A, Yapici HS, Ercan S, Seker M, Ustaalioglu BB, Salman T, Orcun A, Gumus M. Bilici A, et al. Among authors: ercan s. J BUON. 2012 Jul-Sep;17(3):502-7. J BUON. 2012. PMID: 23033289

2

The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.

Ustaalioglu BB, Bilici A, Ercan S, Seker M, Orcun A, Gumus M. Ustaalioglu BB, et al. Among authors: ercan s. Med Oncol. 2013 Jun;30(2):551. doi: 10.1007/s12032-013-0551-6. Epub 2013 Mar 28. Med Oncol. 2013. PMID: 23536001

3

Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?

Bilici A, Ustaalioglu BB, Ercan S, Orcun A, Seker M, Salepci T, Gumus M. Bilici A, et al. Among authors: ercan s. Cancer Chemother Pharmacol. 2011 Aug;68(2):309-16. doi: 10.1007/s00280-010-1480-0. Epub 2010 Oct 22. Cancer Chemother Pharmacol. 2011. PMID: 20967544

4

Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls.

Oven Ustaalioglu B, Bilici A, Ercan S, Orcun A, Seker M, Ozkan A, Ustaalioglu R, Gumus M. Oven Ustaalioglu B, et al. Among authors: ercan s. Clin Transl Oncol. 2012 May;14(5):356-61. doi: 10.1007/s12094-012-0808-0. Clin Transl Oncol. 2012. PMID: 22551541

5

The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.

Bilici A, Ustaalioglu BB, Ercan S, Seker M, Yilmaz BE, Orcun A, Gumus M. Bilici A, et al. Among authors: ercan s. Tumour Biol. 2012 Dec;33(6):2201-8. doi: 10.1007/s13277-012-0481-5. Epub 2012 Aug 14. Tumour Biol. 2012. PMID: 22890829

6

The changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors?

Bilici A, Sonkaya A, Ercan S, Ustaalioglu BB, Seker M, Aliustaoglu M, Orcun A, Gumus M. Bilici A, et al. Among authors: ercan s. Tumour Biol. 2015 Feb;36(2):823-8. doi: 10.1007/s13277-014-2705-3. Epub 2014 Oct 9. Tumour Biol. 2015. PMID: 25296737

7

Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study.

Ercan Ş, Kaymaz Ö, Yücel N, Orçun A. Ercan Ş, et al. Arch Gynecol Obstet. 2012 Mar;285(3):579-84. doi: 10.1007/s00404-011-2025-4. Epub 2011 Jul 27. Arch Gynecol Obstet. 2012. PMID: 21792548

8

Does preeclampsia have any adverse effect on fetal heart?

Akil A, Api O, Oten Can E, Ozkan S, Ercan S, Orcun A, Unal O. Akil A, et al. Among authors: ercan s. J Matern Fetal Neonatal Med. 2016;29(14):2312-5. doi: 10.3109/14767058.2015.1085013. Epub 2015 Sep 18. J Matern Fetal Neonatal Med. 2016. PMID: 26381715 Clinical Trial.

9

Establishing reference intervals for D-dimer to trimesters.

Ercan Ş, Özkan S, Yücel N, Orçun A. Ercan Ş, et al. J Matern Fetal Neonatal Med. 2015 May;28(8):983-7. doi: 10.3109/14767058.2014.940891. Epub 2014 Jul 25. J Matern Fetal Neonatal Med. 2015. PMID: 25060670

10

Establishing biological variation for plasma D-dimer from 25 healthy individuals.

Ercan Ş, Ercan Karadağ M. Ercan Ş, et al. Among authors: ercan karadag m. Scand J Clin Lab Invest. 2021 Oct;81(6):469-474. doi: 10.1080/00365513.2021.1947522. Epub 2021 Jul 8. Scand J Clin Lab Invest. 2021. PMID: 34236255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters